Indications
ARANESP® (darbepoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD), including patients on dialysis and patients not on dialysis.
EPOGEN® (epoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD) in patients on dialysis to decrease the need for READ MORE
EPOGEN® (epoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD) in patients on dialysis to decrease the need for red blood cell (RBC) transfusion.
Limitations of Use:
Your sales team and key account
managers are your source of support for
any questions about ordering or details
about ARANESP® and/or EPOGEN®.
Reinforce your understanding of anemia in
CKD and build your treatment knowledge
with virtual education programs from your
Amgen inside sales team.
An Amgen reimbursement specialist
can assist you with insurance
verification, co-pays, and
reimbursement resources.
Amgen Assist®
1-800-272-9376
In the last 20 years, even in the wake of natural disasters and other disruptive events,
customers have not experienced a supply shortage of ARANESP® or
EPOGEN®.2,†
Learn more about Amgen manufacturing at amgenbiotech.com
LEARN MORE*Based on 99.9% of product shipped to Amgen Authorized Distributors of Record only.
†US wholesalers only (data through March 5, 2021).
AnemiaHUB
Designed specifically for nephrology healthcare providers, AnemiaHUB.com is your comprehensive source for anemia management education.
Not an Anemia HubTM member? Register here
PDF Downloads
References:
ARANESP® (darbepoetin alfa) and EPOGEN® (epoetin alfa) Important Safety Information, including Boxed WARNINGS
WARNING: ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE
Chronic Kidney Disease:
Cancer:
Perisurgery (EPOGEN®):
Please see ARANESP® full Prescribing Information, including Boxed WARNINGS and Medication Guide.
Please see EPOGEN® full Prescribing Information, including Boxed WARNINGS and Medication Guide.
ARANESP® (darbepoetin alfa) and EPOGEN® (epoetin alfa) Important Safety Information, including Boxed WARNINGS
WARNING: ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE
Chronic Kidney Disease:
Cancer:
Perisurgery (EPOGEN®):
Please see ARANESP® full Prescribing Information, including Boxed WARNINGS and Medication Guide.
Please see EPOGEN® full Prescribing Information, including Boxed WARNINGS and Medication Guide.